Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35478
Title: High expression of oleoyl-ACP hydrolase underpins life-threatening respiratory viral diseases.
Austin Authors: Jia, Xiaoxiao;Crawford, Jeremy Chase;Gebregzabher, Deborah;Monson, Ebony A;Mettelman, Robert C;Wan, Yanmin;Ren, Yanqin;Chou, Janet;Novak, Tanya;McQuilten, Hayley A;Clarke, Michele;Bachem, Annabell;Foo, Isabelle J;Fritzlar, Svenja;Carrera Montoya, Julio;Trenerry, Alice M;Nie, Shuai;Leeming, Michael G;Nguyen, Thi H O;Kedzierski, Lukasz;Littler, Dene R;Kueh, Andrew;Cardamone, Tina;Wong, Chinn Yi;Hensen, Luca;Cabug, Aira;Laguna, Jaime Gómez;Agrawal, Mona;Flerlage, Tim;Boyd, David F;Van de Velde, Lee-Ann;Habel, Jennifer R;Loh, Liyen;Koay, Hui-Fern;van de Sandt, Carolien E;Konstantinov, Igor E;Berzins, Stuart P;Flanagan, Katie L;Wakim, Linda M;Herold, Marco J;Green, Amanda M;Smallwood, Heather S;Rossjohn, Jamie;Thwaites, Ryan S;Chiu, Christopher;Scott, Nichollas E;Mackenzie, Jason M;Bedoui, Sammy;Reading, Patrick C;Londrigan, Sarah L;Helbig, Karla J;Randolph, Adrienne G;Thomas, Paul G;Xu, Jianqing;Wang, Zhongfang;Chua, Brendon Y;Kedzierska, Katherine
Affiliation: Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Center for Infectious Diseases Research, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Department of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC 3086, Australia.
Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Shanghai Public Health Clinical Centre and Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Medical College, Fudan University, Shanghai 201508, China.
Shanghai Public Health Clinical Centre, Fudan University, Shanghai 201508, China.
Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital and Department of Anaesthesia, Harvard Medical School, Boston, MA 02115, USA.
Melbourne Mass Spectrometry and Proteomics Facility, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3052, Australia.
Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
Walter Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia.
Department of Anatomy and Physiology, University of Melbourne, Parkville, VIC 3010, Australia.
Department of Anatomy and Comparative Pathology and Toxicology, Pathology and Immunology Group, University of Córdoba, International Excellence Agrifood Campus "CeiA3", 14014 Córdoba, Spain.
Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Department of Molecular, Cell & Developmental Biology, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Department of Cardiothoracic Surgery, Royal Children's Hospital, University of Melbourne, Melbourne Centre for Cardiovascular Genomics and Regenerative Medicine, Parkville, VIC 3052, Australia.
Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia; Institute of Innovation, Science and Sustainability, Federation University Australia, Ballarat, VIC 3353, Australia.
School of Health Sciences and School of Medicine, University of Tasmania, Launceston, TAS 7248, Australia; School of Health and Biomedical Science, RMIT University, Bundoora, VIC 3083, Australia; Tasmanian Vaccine Trial Centre, Clifford Craig Foundation, Launceston General Hospital, Launceston, TAS 7250, Australia.
Olivia Newton-John Cancer Research Institute
Walter Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia.
Center for Infectious Diseases Research, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; Institute of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff, UK.
National Heart and Lung Institute, Imperial College London, London SW7 2AZ, UK.
Department of Infectious Disease, Imperial College London, London, UK.
Department of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC 3086, Australia.
Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital and Department of Anaesthesia, Harvard Medical School, Boston, MA 02115, USA; Center for Influenza Disease and Emergence Response (CIDER), Athens, GA, USA.
Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Center for Infectious Diseases Research, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Center for Influenza Disease and Emergence Response (CIDER), Athens, GA, USA.
Shanghai Public Health Clinical Centre and Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Medical College, Fudan University, Shanghai 201508, China.
Issue Date: 22-Aug-2024
Date: 2024
Publication information: Cell 2024-08-22; 187(17)
Abstract: Respiratory infections cause significant morbidity and mortality, yet it is unclear why some individuals succumb to severe disease. In patients hospitalized with avian A(H7N9) influenza, we investigated early drivers underpinning fatal disease. Transcriptomics strongly linked oleoyl-acyl-carrier-protein (ACP) hydrolase (OLAH), an enzyme mediating fatty acid production, with fatal A(H7N9) early after hospital admission, persisting until death. Recovered patients had low OLAH expression throughout hospitalization. High OLAH levels were also detected in patients hospitalized with life-threatening seasonal influenza, COVID-19, respiratory syncytial virus (RSV), and multisystem inflammatory syndrome in children (MIS-C) but not during mild disease. In olah-/- mice, lethal influenza infection led to survival and mild disease as well as reduced lung viral loads, tissue damage, infection-driven pulmonary cell infiltration, and inflammation. This was underpinned by differential lipid droplet dynamics as well as reduced viral replication and virus-induced inflammation in macrophages. Supplementation of oleic acid, the main product of OLAH, increased influenza replication in macrophages and their inflammatory potential. Our findings define how the expression of OLAH drives life-threatening viral disease.
URI: https://ahro.austin.org.au/austinjspui/handle/1/35478
DOI: 10.1016/j.cell.2024.07.026
ORCID: 
Journal: Cell
Start page: 4586
End page: 4604.e20
PubMed URL: 39137778
ISSN: 1097-4172
Type: Journal Article
Subjects: MIS-C
OLAH
SARS-CoV-2 and RSV
fatal avian A/H7N9 influenza disease
influenza mouse model
life-threatening seasonal influenza
olah(−/−) mice
olah-driven macrophage-mediated disease severity
oleoyl-ACP hydrolase as key early driver of disease severity
COVID-19/virology
COVID-19/genetics
Influenza, Human/virology
Macrophages/metabolism
Macrophages/virology
Lung/virology
Lung/pathology
Lung/metabolism
Oleic Acid/metabolism
Respiratory Syncytial Virus Infections/virology
Carboxylic Ester Hydrolases/metabolism
Carboxylic Ester Hydrolases/genetics
Orthomyxoviridae Infections/virology
Respiratory Tract Infections/virology
Appears in Collections:Journal articles

Show full item record

Page view(s)

16
checked on Dec 20, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.